147 related articles for article (PubMed ID: 29755528)
1. Hypogammaglobulinemia Observed One Year after Rituximab Treatment for Idiopathic Thrombocytopenic Purpura.
Shoukat BA; Ali O; Kumar D; Bilal Gilani M; Zahid A; Aslam Joiya S; Anwar Malik M
Case Rep Med; 2018; 2018():2096186. PubMed ID: 29755528
[TBL] [Abstract][Full Text] [Related]
2. Coexistence of immune thrombocytopenic purpura and idiopathic membranous glomerulonephritis successfully treated with rituximab.
Alkindi S; Khan S; Riyami D; Farooqi M; Pathare A
Platelets; 2010; 21(7):575-7. PubMed ID: 20624006
[TBL] [Abstract][Full Text] [Related]
3. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
[TBL] [Abstract][Full Text] [Related]
4. Concurrent thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in a patient with metastatic neuroendocrine tumour successfully treated with rituximab-CVP.
Bayraktar S; Eileen B; Shariatmadar S; Lian E
BMJ Case Rep; 2010 Nov; 2010():. PubMed ID: 22798444
[TBL] [Abstract][Full Text] [Related]
5. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
6. An idiopathic thrombocytopenic purpura with polyneuropathy.
Katchan V; David P; Shoenfeld Y
Immunol Res; 2017 Feb; 65(1):193-196. PubMed ID: 27427299
[TBL] [Abstract][Full Text] [Related]
7. Post-Partum Thrombotic Thrombocytopenic Purpura (TTP) in a Patient with known Idiopathic (Immune) Thrombocytopenic Purpura: a case report and review of the literature.
Al-Husban N; Al-Kuran O
J Med Case Rep; 2018 Jun; 12(1):147. PubMed ID: 29855343
[TBL] [Abstract][Full Text] [Related]
8. Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy.
Shiuan E; Beckermann KE; Ozgun A; Kelly C; McKean M; McQuade J; Thompson MA; Puzanov I; Greer JP; Rapisuwon S; Postow M; Davies MA; Eroglu Z; Johnson D
J Immunother Cancer; 2017; 5():8. PubMed ID: 28239462
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
[TBL] [Abstract][Full Text] [Related]
10. Long-term Successful Treatment of Rituximab for Steroid-resistant Minimal Change Nephrotic Syndrome and Idiopathic Thrombocytopenic Purpura.
Nishikawa M; Shimada N; Kawazoe T; Sawaki R; Ikuta H; Kanzaki M; Fukuoka K; Fukushima M; Asano K
Intern Med; 2020 Apr; 59(7):983-986. PubMed ID: 31866629
[TBL] [Abstract][Full Text] [Related]
11. Refractory immune thrombocytopenic purpura (ITP) after accessory splenectomy: A case report and literature review.
Riaz A; Ali HT; Ali F; Ali J
Clin Hemorheol Microcirc; 2023; 85(2):189-194. PubMed ID: 37599530
[TBL] [Abstract][Full Text] [Related]
12. Early treatment of rituximab combined with eltrombopag for secondary thrombocytopenic purpura in rheumatoid arthritis: A case report.
Zhang N; Ji C; Bao X; Yuan C
Medicine (Baltimore); 2022 Jan; 101(2):e28417. PubMed ID: 35029180
[TBL] [Abstract][Full Text] [Related]
13. [Enteroviral infections in adults treated with rituximab: A new case of chronic meningitis and myofasciitis and literature review].
Maillet F; Pineton De Chambrun M; Monzani Q; Mercy G; Schuffenecker I; Mirand A; Deback C; Charlotte F; Fourniols E; Mathian A; Amoura Z
Rev Med Interne; 2020 Mar; 41(3):200-205. PubMed ID: 31980187
[TBL] [Abstract][Full Text] [Related]
14. Immune thrombocytopenic purpura presenting in a patient after renal transplant for diabetic nephropathy.
Rashid RM; Nabi Z; Ansari AZ; Qaiser QA
BMC Nephrol; 2018 Mar; 19(1):69. PubMed ID: 29554892
[TBL] [Abstract][Full Text] [Related]
15. Coexistence of thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in an Asian woman: a case report.
Ge H; Shi Z; Zheng Z; Zhu Q; Hong L; Zhang Y; Shen J; Deng S
J Int Med Res; 2022 Mar; 50(3):3000605221085127. PubMed ID: 35352601
[TBL] [Abstract][Full Text] [Related]
16. Immune thrombocytopenic purpura and legionella infection: A case report highlighting the association.
Javed A; Alvi MJ; Sahra S; DeChavez V
IDCases; 2022; 27():e01439. PubMed ID: 35145868
[TBL] [Abstract][Full Text] [Related]
17. [Plasma exchanges as treatment of severe acute immune thrombocytopenic purpura].
Masseau A; Guitton C; Bretonnière C; Renard B; Villers D; Hamidou M
Rev Med Interne; 2005 Oct; 26(10):824-6. PubMed ID: 16084628
[TBL] [Abstract][Full Text] [Related]
18. Successful management of three patients with autoimmune thrombotic thrombocytopenic purpura with paradigm-changing therapy: Caplacizumab, steroids, plasma exchange, rituximab, and intravenous immunoglobulins (CASPERI).
Cid J; Pérez-Valencia AI; Torrente MÁ; Ávarez-Larrán A; Díaz-Ricart M; Esteve J; Lozano M
Transfus Apher Sci; 2021 Feb; 60(1):103011. PubMed ID: 33221124
[TBL] [Abstract][Full Text] [Related]
19. [Recurrent infections in an ITP patient treated with rituximab].
Rosenberg-Bezalel S; Asher I; Sthoeger Z
Harefuah; 2012 Nov; 151(11):617-9, 655. PubMed ID: 23367730
[TBL] [Abstract][Full Text] [Related]
20. [Rituximab and hypogammaglobulinemia].
Fernández Romero DS; Torre MG; Larrauri BJ; Malbrán E; Juri MC; Malbrán A
Medicina (B Aires); 2015; 75(5):319-23. PubMed ID: 26502469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
